Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thiosalicylic acid is an organosulfur compound with carboxyl and sulfhydryl functional groups. It acts as a non-narcotic analgesic and antipyretic, and is used (primarily as its sodium salt) to relieve symptoms of acute gout, painful musculoskeletal conditions, osteoarthritis, and rheumatic fever. Its mechanism of action involves inhibition of prostaglandin synthesis. Thiosalicylic acid has also been used as a precursor in the synthesis of other compounds such as the vaccine preservative thiomersal and the dyestuff thioindigo. It is associated with risks such as contact dermatitis[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Thiosalicylic acid.